back to top

Down Syndrome Screening at HOPE Women’s Hospital

Down syndrome screening is a prenatal test used to assess the risk of having a baby with Down syndrome, a genetic condition characterized by intellectual disability and certain physical features. The screening involves a combination of maternal age assessment, ultrasound measurements, and blood tests to estimate the likelihood of Down syndrome in the fetus. At HOPE Women’s Hospital, we offer comprehensive Down syndrome screening services to provide expectant parents with information about their baby’s health and help them make informed decisions during pregnancy.

Understanding Down Syndrome

Down syndrome, also known as trisomy 21, is a genetic condition caused by the presence of an extra copy of chromosome 21. It is one of the most common genetic disorders, affecting approximately 1 in 700 births worldwide. Individuals with Down syndrome may have:

  • Intellectual Disability: Mild to moderate cognitive impairment affecting learning, language development, and social skills.
  • Physical Features: Certain facial characteristics such as a flat facial profile, almond-shaped eyes, small ears, and a protruding tongue.
  • Health Issues: Increased risk of congenital heart defects, gastrointestinal problems, hearing loss, vision problems, and other medical conditions.
  • Developmental Delays: Delayed motor skills, speech and language development, and adaptive functioning compared to typically developing individuals.
  • Lifespan and Quality of Life: Improved healthcare and support services have increased life expectancy and quality of life for individuals with Down syndrome.

Types of Down Syndrome Screening

   
  • There are two main types of Down syndrome screening tests:
  • First-Trimester Screening: This includes a combination of ultrasound measurement of fetal nuchal translucency (fluid at the back of the baby’s neck) and maternal blood tests (serum markers) such as pregnancy-associated plasma protein-A (PAPP-A) and human chorionic gonadotropin (hCG). The results are used to calculate the risk of Down syndrome.
  • Second-Trimester Screening: Also known as the quad screen or quadruple test, this involves maternal blood tests (serum markers) to measure levels of alpha-fetoprotein (AFP), hCG, unconjugated estriol (uE3), and inhibin A. These markers, along with maternal age, are used to estimate the risk of Down syndrome and other chromosomal abnormalities.

Indications for Down Syndrome Screening

   
  • Down syndrome screening may be recommended for pregnant individuals based on:
  • Maternal Age: Advanced maternal age (35 years or older) is associated with an increased risk of having a baby with Down syndrome.
  • Previous Pregnancy History: Individuals with a history of chromosomal abnormalities or pregnancies affected by Down syndrome may be offered screening.
  • Family History: In some cases, a family history of genetic conditions or chromosomal abnormalities may warrant Down syndrome screening.
  • Abnormal Ultrasound Findings: Certain ultrasound findings, such as increased nuchal translucency or structural abnormalities, may prompt further screening for Down syndrome.

Benefits of Down Syndrome Screening

  • Risk Assessment: Down syndrome screening helps assess the risk of having a baby with Down syndrome, providing expectant parents with valuable information about their pregnancy.
  • Informed Decision-Making: Screening results empower parents to make informed decisions about additional diagnostic testing, prenatal care, and future plans for their baby.
  • Early Intervention: Early detection of Down syndrome allows for early intervention services, medical monitoring, and support for the baby and family.
  • Emotional Preparation: Knowing the risk of Down syndrome during pregnancy allows parents to emotionally prepare for the possibility and seek appropriate support and resources.
  • Individualized Care: Screening results guide healthcare providers in providing individualized prenatal care, monitoring, and planning for delivery and postnatal care.
  • The Down Syndrome Screening Process

  • The Down syndrome screening process typically involves the following steps:
  • Consultation: Expectant parents meet with their healthcare provider to discuss the purpose, benefits, and limitations of Down syndrome screening.
  • Maternal Age Assessment: Maternal age is a key factor in determining the risk of Down syndrome, with advanced maternal age associated with higher risk.
  • Ultrasound: During the first trimester, an ultrasound is performed to measure fetal nuchal translucency (NT), a marker for chromosomal abnormalities including Down syndrome.
  • Blood Tests: Maternal blood tests are conducted to measure specific markers (serum markers) associated with Down syndrome risk, such as PAPP-A, hCG, AFP, uE3, and inhibin A.
  • Risk Calculation: The results of ultrasound measurements, serum markers, and maternal age are combined to calculate the risk of Down syndrome. The risk is typically expressed as a probability (e.g., 1 in 100, 1 in 1,000).
  • Screening Results: Expectant parents receive the screening results and discuss options for further testing, such as diagnostic testing (amniocentesis or chorionic villus sampling) for confirmation of Down syndrome.
  • Interpreting Down Syndrome Screening Results

    Low Risk: A low-risk screening result indicates a low probability of having a baby with Down syndrome. Further diagnostic testing may not be necessary for low-risk pregnancies.
    Intermediate Risk: An intermediate-risk result suggests a moderate probability of Down syndrome. Healthcare providers may offer additional testing or discuss options based on individual circumstances.
    High Risk: A high-risk screening result indicates an increased probability of having a baby with Down syndrome. Further diagnostic testing, such as amniocentesis or chorionic villus sampling, is recommended for confirmation.

    Genetic Counselling and Support

    At HOPE Women's Hospital, we offer genetic counselling and support services for individuals and families undergoing Down syndrome screening. Our genetic counsellors provide:
    Pre-Test Counselling: Information, education, and counselling before Down syndrome screening to help individuals understand the purpose, process, and potential outcomes.
    Post-Test Counselling: Interpretation of screening results, discussion of options for further testing, emotional support, and guidance for decision-making.
    Resource Referrals: Referrals to community resources, support groups, advocacy organizations, and healthcare specialists for additional support and information.
    Family-Centered Care: Compassionate, family-centered care to address the unique needs, concerns, and preferences of expectant parents and families.

    sec-title-s-1-1
    GET APPOINTMENT

    Schedule Your Consultation

    APPOINTMENT

    If you are pregnant and considering Down syndrome screening, schedule a consultation with our healthcare team at HOPE Women's Hospital. Our experienced providers and genetic counsellors are dedicated to supporting you throughout the screening process, providing personalized care, and helping you make informed decisions about your pregnancy and baby's health.

      appointment-shape-1-1